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1. Introduction 
Glucose homeostasis requires hormonal and neural mechanisms in an attempt to get a 
normal functioning of the brain and of peripheral tissues. Blood glucose levels must be 
maintained within a physiological range depending of feeding and hormonal status, having 
the alterations of normoglycemic levels deleterious consequences. Hypothalamus plays a 
major role on feeding behaviour and energy homeostasis. It contains the called "satiety 
centre" and "hunger centre" located in ventromedial (VMH) and lateral hypothalamus (LH) 
respectively. These brain areas, besides others, may be altered by metabolic signals, such as 
changes in the electrical activity of neurons by direct application of glucose or by 
modifications of blood glucose levels. In this regard, glucose activates or inhibits neuronal 
activity, and both responses suggest the presence of glucose sensors in these brain areas. 
Glucose sensors are molecular designs responsible for detecting and measuring glucose 
concentrations in the extracellular space. Thus, glucose sensor are presents in gut, endocrine 
pancreatic cells, portal vein, central nervous system and rare neuroendocrine cells, and they 
are responsible to avoid marked blood glucose oscillations, which permit to maintain 
glucose homeostasis. 
First evidence of the existence of a glucose sensor system was reported in pancreatic beta-
cells (Matschinsky 1990), constituted by glucokinase (GK). GK catalyses glucose 
phosphorylation with low afffinity and it is not inhibited by its product (glucose-6-
phosphate), which allows increased glucose utilization as its concentration rises. Due to GK 
properties, the glucose catabolism rate is proportional to glucose levels in the extracellular 
space and for that reason GK is the major contributor to glucose sense, since catalyses the 
rate-limiting step of glucose catabolism. Interestingly, glucose transporter isoform 2 (GLUT-
2) also with a high Km for glucose transport, has a different role since glucose transport 
occurs in both directions of the beta-cell membrane and glucose transport is 100-fold higher 
that the rates of glucose metabolism. 
Our previous findings (Alvarez et al., 1996; Navarro et al., 1996) indicating the presence of 
GK together with GLUT-2 and glucagon-like peptide-1 receptor (GLP-1R) in the same cells 
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of hypothalamic areas implied in the control of feeding behaviour, suggest that a glucose 
sensor system may be present in those structures as discussed in the section 3.  
GLP-1, together with others peptides, such as leptin, insulin, GLP-2, are anorexigenic 
peptides that acts in hypothalamic areas contributing to generate a state of satiety. By the 
contrary peptides orexigenic such as neuropeptide Y (NPY), orexin, galanin, ghrelin, etc, 
contribute to increase food intake.  These effects may be the results of an accurate molecular 
crosstalk between the cells which secrete these peptides and the glucose sensing cells. 
The importance of GK in the hypothalamic glucose sensing and its relation with 
anorexigenic and orexigenic peptides are discussed in this chapter.  
2. Brain glucose sensor 
Glucose is needed as an energy substrate but also as a signaling molecule in several 
processes. Glucoregulatory mechanisms are of primary functional concern to provide a 
continued glucose supply to the central neurons system and to face metabolic needs of 
peripheral tissues. Alterations of normoglycemic levels have deleterious consequences that 
increase the morbidity and mortality rates of the population.  
In the 1950´s, the glucostatic hypothesis (Mayer 1953) postulated that glucose receptors exist 
in the hypothalamus and possibly in other central and peripheral regions involved in the 
regulation of food intake. Thus, glucose balance should be tightly regulated and taking into 
account the pancreatic glucose sensor concept, it would be reasonable to suggest the 
existence of a similar system in the brain that might modulate feeding behaviour and the 
release of counteregulatory hormones that defend against hypoglycemia. We proposed 
(Alvarez et al., 1996; Navarro et al., 1996) that the hypothalamus senses plasma glucose 
levels in a similar fashion to beta-cells, causing changes in the expression and secretion of 
neuropeptides (Yang et al., 2004). Our findings indicated that GK mRNA and protein are 
coexpressed together with GLUT-2 in the hypothalamus of human and experimental 
animals, mainly in areas involved in the control of food intake such as VMH and LH 
(Navarro et al., 1996; Roncero et al., 2000). Taking into account these studies, it have been 
addressed central role of GK as glucose sensor,  reinforced by GLUT-2, the K+ATP channel 
subunits SUR1 and SUR2, as well as Kir6.2, in central glucose sensing (Jordan et al., 2010). 
By analogy with the beta-cell, the general idea is that the glucose metabolism and variations 
in ratio ATP/ADP are the keys for neural sensing of glucose. However the ATP metabolism 
is a general mechanism for any electrical response, while neurons produce specific electrical 
responses. Others authors have proposed relationship between neuronal glucose-sensing 
and electrical responses (Figure 1). These hypothesis include electrogenic glucose entry, the 
existence of specific non-transporting detectors of extracellular glucose or glucose receptors 
and the possibility that glial cells would be responsible of glucose changes detection.  
An example of electrogenic glucose entry to neuron is the mediated by the sodium–glucose 
co-transporters (SGLTs), where glucose is directly coupled to Na+ ion movement. That entry 
is directly conditioned by extracellular glucose concentration. This mechanism is used in the 
secretion of GLP-1 by intestinal cells in response to glucose (Gribble et al., 2003) and in the 
excitability of glucose-response neurons of VMH and arcuate nucleus (ARC) (Yang et al., 
1999) that will comment below. 
Diez-Sampedro suggest the existence of a “glucose receptor” that mediates the changes in 
electrical activitiy (Diez-Sampedro et al., 2003). Thus, in some peripheral neurons, have been 
identified a glucose transporter protein (SGLT3/SLC5A4) that not transport glucose into the 
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cell, instead, this protein acted as a sensing receptor, converting elevations of extracellular 
glucose into Na+-dependent depolarization of the membrane (Figure 1). 
An additional hypothesis (Pellerin & Magistretti 2004) is that astrocytes could be the 
primary physiological detectors of extracellular glucose changes. This model proposed that 
rise in extracellular glucose induce glial lactate production which is transported from glia 
and into the neurons by lactate transporter (MCT1) and trigger the depolarization and 
excitation of neurons by closing the K+ATP channels (Burdakov & Ashcroft 2002) (Figure 1). 
2.1 Glucose-inhibited (GI) and glucose-excited (GE) neurons 
Claude Bernard showed the earliest evidence that the brain is involved in glycemic control 
since the lesion of the hypothalamus in dog, induced hyperglycemia (Bernard 1849). Later, 
Jean Mayer (Mayer 1953) proposed that hypothalamic cells could monitor plasma glucose 
variations and postulated that these cells transduced variations of glucose concentrations into 
electrical or chemical signals that control feeding behavior. Electrophysiological studies carried 
out in hypothalamic slices, demonstrated the existence of  neurons able to modulate their 
firing activity in response to changes in extracellular glucose levels (Anand et al., 1964). These 
are glucose-excited (GE; previously called glucose-responsive) neurons, which increase their 
firing rate with elevation of glucose concentrations in extracellular, or glucose-inhibited (GI; 
previously called glucose-sensitive) neurons, which are activated by a decrease in extracellular 
glucose concentration or by cellular glucoprivation (Routh 2002; Yang et al., 2004). 
 
 
Fig. 1. Signalling pathways proposed to be involved in glucose sensing by hypothalamic 
neurons. A) Signalling pathways of glucose-metabolism-triggered electrical responses for 
neural sensing of glucose. Red lines indicate the canonical pathways share with beta-cell. 
Other signalling pathways could be mediate by previous glucose metabolization to lactate 
by glial cells. B) Pathways that triggers glucose metabolism-independent electrical 
responses. These pathways involved electrogenic glucose entry through sodium-glucose 
cotransporters (SGLT) or the presence of glucose receptors 
www.intechopen.com
 Update on Mechanisms of Hormone Action – Focus on Metabolism, Growth and Reproduction 
 
36
Although both types of neurons are widely distributed in the brain, they are highly present 
in regions involved in the control of energy homeostasis and food intake such as 
hypothalamic nuclei and the brain stem (Adachi et al., 1995). Additionally it has been 
recently reported a novel glucose-sensing region in the medial amygdalar nucleus (Zhou et 
al., 2010). 
The existence of glucose-regulated neurons has been studied by intravenous or 
intracerebroventricular injections of 2-deoxyglucose or 5-thio-glucose and posterior 
electrophysiological recordings or by the detection c-fos-like immunoreactivity (which is 
highly expressed in activated neurons). Using these approaches, responsive neurons have 
been found in the VMH, paraventricular (PVN) and LH, ARC, parabrachial nucleus (PBN), 
nucleus tractus solitarius (NTS), area postrema (AP), dorsal motor nucleus of the vagus 
(DMNX), and the region of the basolateral medulla (BLM) (Ritter & Dinh 1994; Dallaporta et 
al., 1999).  
2.2 Electrophysiological pattern  
Diverse signalling pathways are involved in the modulation of the electrical activity of 
hypothalamic neurons by glucose. On the one hand, glucose could alter neuronal electrical 
activity acting as energy substrate by influencing energy metabolism inside neuron and glia 
cells (Figure 1). On the other hand glucose could be considerer as an extracellular signalling 
messenger that could trigger specific glucose receptors controlling the membrane ion fluxes. 
Other possibility could be that glucose itself can be transported by electrogenic transporters 
(Figure 1). Which of these general mechanisms is dominant in different glucose-sensing 
neurons remains to be determined.  
The mechanisms regulating GE cells have been more thoroughly understood and were 
assumed to employ a beta-cell glucosensing strategy. Thus, glucose enters the beta-cell via 
GLUT-2, facilitating its diffusion down a concentration gradient. Then GK phosphorylates 
glucose allowing for its entry into the glycolytic pathway that leads to an increase in the 
ATP. The consequent increase in the cytosolic ATP/ADP concentration ratio then closes the 
K+ATP channels. In the beta-cell, these channels are made up of Kir6.2/SUR1 subunits 
(Ashcroft & Rorsman 2004). Since open K+ATP channels generate hyperpolarization of the 
beta-cell and so dampen its excitability, their closure results in decreasing potassium 
outflow and depolarization with increased electrical activity. Actually, GK are the key 
glucose-sensing features of this scheme because they ensure that changes in extracellular 
glucose levels within the physiological range are converted to proportional changes in 
electrical excitability. This is due to the low affinity for glucose of GK, unlike the more 
ubiquitously expressed hexokinase I, and that GK is not inhibited by its product, glucose-6-
phosphate.  
The functional importance of GK in GE neurons was studied by pharmacological inhibition 
which decreased neuronal activity. In vitro studies on primary VMH cultures have shown 
that selective downregulation of GK leads to selective loss of glucose sensing and a decrease 
in cellular ATP concentration corresponding with an increase in K+ATP channel activation 
(Dunn-Meynell et al., 2002; Kang et al., 2006). This supports the model that inhibition of GK, 
in at least a proportion of GE neurons, reduces ATP production causing K+ATP channel 
opening and cell hyperpolarization. Recent findings indicate that although elements of 
canonical model used in beta-cell, are functional in some hypothalamic cells, this pathway is 
not universally essential for excitation of glucose-sensing neurons by glucose. In rats and 
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humans, the expression of GLUT-2, GK (Navarro et al., 1996; Roncero et al., 2000) and Kir6.2 
was found in some but not all GE neurons (Kang et al., 2004) and were also present in non-
glucose-sensing neurons (Lynch et al., 2000). For example, glucose-induced excitation of 
ARC neurons was recently reported in mice lacking Kir6.2, and no significant increases in 
cytosolic ATP levels could be detected in hypothalamic neurons after changes in extracellular 
glucose. Thus, the molecular support for the idea that all GE neurons rely on the beta-cell tools 
to sense glucose is currently inconclusive and possible alternative glucose-sensing strategies 
could include electrogenic glucose entry, glucose-induced release of glial lactate, and 
extracellular glucose receptors (Pellerin & Magistretti 2004; Burdakov et al., 2005). 
Much less is known about GI neurons and whether these neurons follow the same glucose 
sensing strategy remains unclear (Burdakov & Lesage 2010). It has been proposed to involve 
reduction in the depolarizing activity of the Na+/K+ pump, or activation of a 
hyperpolarizing Cl- current. Although it has been suggested that the metabolic model of 
glucose sensing applies to GI neurons, there is convincing evidence for metabolism-
independent neuronal glucose sensing in GI neurons. As it has been mentioned, Kang 
group’s (Kang et al., 2004) showed that some but not all glucose sensing neurons of the 
VMN express GK and SUR1, suggesting that other regulatory mechanisms must control 
glucose sensing in some of these neurons. Furthermore, Gonzalez et al (Gonzalez et al., 
2009), used direct electrophysiological measurements of glucose sensing orexin neurons to 
show that metabolism independent glucose sensing exists in GI neurons. They found that 
GK inhibitors do not block glucose sensing in these neurons. However, despite the evidence 
for metabolism-independent as well as dependent glucose sensing mechanisms, the nature 
of the glucose sensing machinery in GI neurons remains unclear.  
2.3 Hypothalamic distribution of GE and GI neurons 
Hypothalamic glucose-sensing neurons comprise subgroups of cells in PVN, LH, ARC, 
VMH hypothalamic regions, and can be either electrically inhibited or excited by elevations 
in extracellular glucose (Anand et al., 1964; Oomura et al., 1969; Routh 2002; Wang et al., 
2004). The distribution of GE glucose response neurons in the hypothalamus are confinated 
mostly to the VMH, ARC, and PVN (Dunn-Meynell et al., 1998; Silver & Erecinska 1998; 
Wang et al., 2004). However, GI neurons are found mainly in the LH (Oomura et al., 1974), 
median ARC, and PVN.  
There are two major subpopulations of neurons in the ARC of the hypothalamus implicated 
in the control of feeding. One population contains pro-opiomelanocortin (POMC) and ┙-
melanocyte-stimulating hormone (┙-MSH) that are anorexigenic peptides and inhibits food 
intake. The second population of neurons contains agouti-related protein (AgRP) and 
neuropeptide Y (NPY) orexigenic peptides that stimulate food intake (Cone et al., 2001). GI 
neurons are present in the VMN in the ARC and in the LH and partly overlap with the 
orexigenic NPY/AgRP and possibly orexin neurons. GE neurons correspond in part to 
POMC neurons in the VMN and possibly in the ARC and POMC neurons in the LH 
(Mountjoy & Rutter 2007).  
2.4 Effect of glucose concentrations on the brain glucose sensors 
Some of the glucose-sensing neurons in the LH, ARC and VMH hypothalamic regions 
electrically respond to changes in glucose within the physiological ranges of glucose (Wang 
et al., 2004; Burdakov et al., 2005; Song & Routh 2005). As a general rule, the extracellular 
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concentration of glucose in the brain is 10–30% of that in the blood (Silver & Erecinska 1998). 
During euglycemia, brain glucose levels are 0.7-2.5 mM, and may be reached 5mM under 
severe plasma hyperglycemia. On the other hand, plasma hypoglycaemia can cause the 
brain glucose to fall to 0.2-0.5 mM. Changes in plasma glucose corresponding to meal-to-
meal fluctuation (about 5–8 mM) (Silver & Erecinska 1994) lead to changes in glucose 
concentration in the brain that it is expected to be in the range between 1 and 2.5 mM (Routh 
2002). It is also noteworthy that glucose-sensing neurons located near regions with a 
reduced blood–brain barrier for example, the median eminence region that neighbors the 
hypothalamic ARC (Elmquist et al., 1999), may be exposed to a much higher glucose 
concentrations than other brain cells, even approaching those present in the plasma. If this is 
the case, for glucose-sensing neurons of the ARC, high glucose concentrations (greater than 
5 mM) may well comprise a physiologically relevant stimulus (Fioramonti et al., 2004) . In 
this way, it has been described in the ARC, the presence of GE and GI neurons responsive to 
glucose over either a low (0–5 mM) or a high glucose concentration range (5–20 mM); the 
latter are referred to as high GE (HGE ) or high GI (HGI) neurons, respectively (Fioramonti 
et al., 2004; Penicaud et al., 2006).  
More details about the effect of glucose oscillations in the glucose sensor GK will be 
discussed in the section 4 of this chapter. 
3. Glucokinase as part of a hypothalamic glucose sensor system  
GK is a member of the hexokinase family (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1) 
that catalyses the phosphorylation of glucose to glucose 6-phosphate. Hexokinases I, II and 
III have a high affinity for glucose, with low Km (Michaelis constant) values in the 
micromolar range. GK or hexokinase type IV has a low affinity for glucose; it is not inhibited 
by physiological concentrations of glucose 6-phosphate, and has a molecular mass of about 
50 kDa  (Iynedjian 1993) 
For years, the liver and the pancreatic islets were considered to be the only tissues in which 
GK activity could be detected. Later on, GK mRNAs of appropriate sizes were found in the 
corticotroph anterior pituitary cell line AtT-20, in rat pituitaries (Hughes et al., 1991) and in  
brain and intestine of the rat, but no enzyme activity was reported in neither (Jetton et al., 
1994; Alvarez et al., 1996; Navarro et al., 1996). However, Roncero et al 2000 described that 
GK gene expression in rat brain gave rise to a protein of 52 kDa, with a high Km 
phosphorylating activity. Brain GK showed kinetic properties similar to those previously 
reported for the enzyme of hepatic or pancreatic islet origin. It has a high apparent Km for 
glucose (8.9–15 mM) and displays no product inhibition by glucose 6-phosphate. The 
contribution of GK to the total glucose phosphorylating activity was 40–19% in different 
cerebral regions, measured with a radiometric assay, and of 25–14% as determined by a 
spectrophotometric method.  
The presence of tissue-specific promoters in the GK gen allows differential regulation. The 
upstream promoter, now rightly called neuro-endocrine promoter to distinguish it from the 
hepatic promoter (Iynedjian et al., 1996; Levin et al., 2004), is functional in beta-cells and in the 
brain (Magnuson & Shelton 1989; Roncero et al., 2000), while the downstream promoter is 
used only in liver . GK levels in beta-cells appear to be controlled by glucose, probably through 
a post-transcriptional mechanism (Iynedjian 1993; Matschinsky et al., 1993). In contrast, the 
liver-specific promoter is mainly affected by insulin and glucagon, which explains the 
extraordinary transcriptional regulation by the nutritional state (Iynedjian 1993). 
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The short-term regulation of GK activity involves several mechanisms: Long-chain fatty 
acyl-CoAs have been shown to be allosteric competitive inhibitors in vitro of the liver 
enzyme (Tippett & Neet 1982) and human beta-cell GK (Moukil et al., 2000). Glucose 
regulates the activity of GK through a “mnemonic” mechanism, which increases the activity 
of liver GK in the presence of high levels of glucose and decreases it when the glucose level 
is low (Cornish-Bowden & Storer 1986). GK activity in the liver is also regulated by the GK 
regulatory protein (GKRP), which behaves as a competitive inhibitor of GK. In the presence 
of fructose 6-phosphate GKRP binds to GK and inhibits its activity, whereas fructose 1-
phosphate prevents the formation of the complex GKRP-GK (Van Schaftingen 1989). GKRP 
is not only a protein that binds and inactivates GK, but also regulates the translocation of 
GK between the cytoplasm and the nucleus. When glycogenolysis and/or gluconeogenesis 
are activated, the concentration of fructose 6-phosphate increases in the liver and produces 
the inhibition of GK, which facilitates the release of glucose by the liver. When carbohydrates 
are present in the diet, fructose is phosphorylated to fructose-1 phosphate, which favours 
glucose utilization by the liver (Agius & Peak 1993; Toyoda et al., 1995; Shiota et al., 1999). 
Thus, in the liver, the subcellular translocation of GK regulates the enzyme activity in 
accordance with the metabolic needs of the cells. It is therefore accepted that translocation of 
GK to the nucleus at low glucose concentrations needs GKRP as an anchoring protein that 
allows transport through the nuclear pore complex. However, it is unclear whether the nuclear 
export of GK requires GKRP. In pancreatic islets, GK activity may also be regulated by a 
protein, in a similar way to that described in hepatocytes (Malaisse et al., 1990).  
Subsequent research has also identified several GK binding proteins that could act as 
cytoplasmic binding proteins. They include a dual-specificity protein phosphatase, the 
glucokinase-associated phosphatase (Munoz-Alonso et al., 2000), and the bifunctional 
enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (Baltrusch et al., 2001). 
Other studies indicate that a minor fraction of GK and GKRP may be integrated in a 
multienzyme complex, including the pro-apoptotic protein BAD, and become associates 
with mitochondria in hepatocytes (Arden et al., 2006). These data suggest the existence of 
different pools of cytoplasmic GK with specialized metabolic functions (Arden et al., 2006). 
It has also been reported that AMP-activated protein kinase (AMPK) inhibits GK 
translocation from the nucleus. 
In pancreatic beta-cells GK is considered to be a true glucose sensor (Matschinsky 1990) 
involved in glucose-dependent insulin release. The GK glucose sensor concept is supported 
by the fact that GK mutations are responsible for some types of maturity-onset diabetes of 
the young-2 (MODY-2) (Vionnet et al., 1992) and for persistent hyperinsulinaemic 
hypoglycaemia in infancy (PHHI) (Christesen et al., 2002). In addition, as noted above, 
targeted disruption of the GK gene in the beta-cells of mice produces severe alterations in 
insulin release (Grupe et al., 1995). 
3.1 Expression, activity and localization of hypothalamic GK and glucokinase 
regulatory protein (GKRP) in the hypothalamus 
Several brain areas, such as the LH and VMH and the dorsomedial medulla oblongata, 
including the NTS and the motor nucleus of the vagus, modulate glucose homeostasis in the 
liver and pancreas (Oomura & Yoshimatsu 1984). As previously cited, glucose is mainly 
excitatory in the VMH and inhibitory in the LH and NTS (Oomura & Yoshimatsu 1984), 
suggesting the presence of glucose sensors in neurons of these brain areas. Indeed, 
stimulation of glucoreceptors present in the neurons of the VMH, promotes the release of 
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the counter-regulatory hormones, catecholamines and glucagon, which defend the organism 
against glucopenia (Borg et al., 1995). 
Our findings, indicate that GLUT-2, GK and GLP-1R are expressed in the same cells of the 
rat and human hypothalamus (Alvarez et al., 1996) (Figure 2), and are located in areas 
involved in the regulation of energy homeostasis, feeding behaviour and glucose 
metabolism. It is noteworthy that in the brain, GLP-1 contributes to reducing food intake 
(Navarro et al., 1996; Turton et al., 1996), and the co-localization of those three components 
in hypothalamic neurons suggests that a glucose sensor system may be involved in the 
transduction of signals required to produce a state of satiety. 
As we previously cited, GK activity may also be regulated by GKRP, acting in accordance 
with the metabolic needs of the cells (Van Schaftingen et al., 1984; Shiota et al., 1999; 
Roncero et al., 2004). Interestingly, we reported the coexpression of GK and GKRP in both 
rat and human brains (Roncero et al., 2000; Alvarez et al., 2002; Roncero et al., 2004), as well 
as GKRP interacting with GK in the presence of fructose-6-phosphate, which suggests that 
both are active and both may participate in the glucosensing process in the central nervous 
system (Alvarez et al., 2002). 
 
 
Fig. 2. In situ hybridization histochemistry of GLP-1R and GLUT-2 or GK mRNAs. A 
double-labeling of GLP-1R and GLUT-2 mRNAs in the VMH. B Double-labeling of GLP-1R 
and GK mRNAs in the VMH. Silver grains indicate the localization of either GLUT-2 or GK 
mRNAs. Blue reaction product indicates labelling of GLP-1R mRNAs. (Microphotographs 
suministrated by Dr. J. Chowen) 
GK and GKRP have been found in foetal pancreas and liver (Vandercammen & Van 
Schaftingen 1993; Garcia-Flores et al., 2002). Also in foetal hypothalamus GK mRNA was 
present in day 18 of development (Sutherland et al., 2005). Our result concluded that GK 
and GKRP were functionally active before birth in the rat brain. Both proteins colocalised in 
the same cells of hypothalamus and the cerebral cortex of 21-day-old foetuses (F-21) 
(Roncero et al., 2009) (Figure 3).  
The presence of GK mRNA was confirmed in approximately 50% of GE and GI neurons in 
the VMH. Some of these neurons also contained mRNAs for subunits of K+ATP channels 
(Kang et al., 2004). The use of specific small interfering RNA (siRNA) to knock-down GK in 
primary cultures of neurons from the rat VMH, abolished  the responses to glucose (Kang et 
al., 2006). Together, these findings supported the idea that GK was the glucose sensor of at 
least a fraction of VMH neurons, functioning as the rate determining enzyme of glucose 
metabolism and controlling neuronal excitability. In the VMH, GK mRNA was shown to be 
expressed in neurons synthesizing POMC and NPY/AgRP, which play critical roles in 
neural pathways involved in the regulation of food intake and energy expenditure. 
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Fig. 3. GK and GKRP detection in the hypothalamus. Inmunofluorescent detection of GK 
(green b) or GKRP (red c) proteins in VMH from twenty-one-day old foetuses. Nuclear 
staining (a) was carried out in blue with 4,6-diamid-o-2-phenylindole (DAPI). The arrows 
(d) indicate the double positive cells for GK and GKRP. 
4. Regulation of hypothalamic GK by glucose or regulatory peptides 
The glucose-sensing neurons have receptors for orexigenic and anorexigenic 
neuropeptides that may modulate feeding behaviour through a glucose sensor system 
(Schuit et al., 2001).  
The effects of orexigenic and anorexigenic peptides and glucose on GK gene expression 
were tested (Sanz et al., 2007) in GT1-7 immortalized hypothalamic neurons, which are 
glucose-sensing cells (Lee et al., 2005) able to respond to glucose deprivation or high-glucose 
levels, as well as having intrinsic GK activity. Neither the promoter activity of the GK gene 
in transfected GT1-7 cells nor the endogenous GK gene expression were modified by the 
action of different concentrations of glucose or GLP-1, leptin, or NPY in the extracellular 
space. However, GK enzyme activities were modified by these peptides.  
Using hypothalamic slices in culture, instead cell line, which it is a better physiological 
model, the effect of glucose orexigenic and anorexigenic peptides on GK activities in VMH 
and LH areas were assayed. In the VMH there was a tendency for GK activities to increase 
as glucose rose in the extracellular media and high-GK activity was found at lower glucose 
concentrations in the LH. These findings could reflect a different type of behavior for the GE 
and GI neurons located in the VMH and the LH, when challenged by different 
concentrations of glucose. This would be in agreement with the tendency of GK activity to 
increase with rises in glucose in the range of 0.5–20 mM that was reported in the VMH (Sanz 
et al., 2007), while neurons in LH were not excited by the higher concentrations of glucose 
but by lower concentrations of this hexose, as happens with GK activities (Sanz et al., 2007). 
The observed changes in GK activity in response to glucose in certain hypothalamic areas 
suggest that such activity would not only be tissue-specific but also even cell-specific in 
defined brain areas. Interestingly, GK activities were thus significantly lower in LH than in 
VMH at high glucose concentrations, but this effect was reversed by the presence of insulin. 
This distinctive response observed in LH at high glucose may be related to different 
functional activities of these two areas, rather than to other kind of effects. The data 
obtained in these studies indicate a different response to glucose levels in the VMH and LH 
and also that some orexigenic and anorexigenic peptides might modulate GK activities in 
neurons of these areas. Additionally, it suggests that in most of the cases modifications of 
hypothalamic GK occur at the enzyme activity level rather than in transcriptional 
expression. 
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5. Role of hypothalamic GK on the control of feeding behaviour and body 
weight 
Coexpression of  GLUT-2, GK and GKRP in areas involved in feeding behaviour (Roncero et 
al., 2000; Roncero et al., 2004) might play a role in glucose sensing, in which GK and GKRP 
made possible a real sensor activity. Furthermore the effects of anorexigenic and orexigenic 
peptides through its receptors in this system should facilitate the transduction of signals 
required to produce a state of satiety. In fact, we have reported experimental evidences that 
GLP-1 is an anorexigenic peptide and controls the glucose metabolism in the human 
hypothalamus areas involved in the regulation of feeding behaviour (Alvarez et al., 2005) 
(Navarro et al., 1996). 
5.1 Anorexigenic and orexigenic peptides  
Early suggestions that hypothalamus plays a major role on feeding behaviour and energy 
homeostasis were obtained after brain lesion and stimulation studies. Remembering these 
observations, such as electrical stimulation of VMH suppress food intake and that bilateral 
lesions of these structures induce hyperphagia and obesity, VMH was named as the satiety 
centre, while alterations of LH induced the opposite set of responses and thus was called the 
hunger centre. Also, the dorsomedial medulla oblongata, including the NTS and the motor 
nucleus of the vagus, are implied in these processes. Now, we know the existence of specific 
subpopulations of neurons involved in energy homeostasis that are included in neuronal 
pathways with anorexigenic and orexigenic biomolecules (table 1), that generate integrated 
responses to afferent stimuli related to modifications in metabolites or in fuels storage. 
The VMH is the responsible for integrating peripheral signals of nutrient status and 
adiposity.  For example, the ARC contains neurons secreting the NPY and POMC. These 
neuropeptides have opposite effects on energy homeostasis, since NPY increases food intake 
and inhibit energy expenditure, while POMC exerts the contrary effects (Adage et al., 2001). 
Other studies suggest that some VMH neurons are GABAergic, although there is not a clear 
relationship to glucose-sensing capacity. More recent findings show that most VMH 
neurons express the protein steroidogenic factor-1 (SF-1) and that SF-1-positives neurons 
have key roles in glucose homeostasis (Tong et al., 2007; Tsuneki et al., 2010). The LH cells 
contain the peptides orexins/hypocretins, which are not expressed anywhere else in the 
brain (de Lecea et al., 1998; Sakurai et al., 1998). Lack of orexin/hypocretin produces 
hypophagia and late onset obesity among others effects (Hara et al., 2001). 
A number of peptidic hormones, previously thought to be specific to the 
gastroenteropancreatic system and later found also in the mammalian brain, have been 
shown to modulate appetite, energy, and body weight. They play these physiological effects 
together with other biomolecules such as NPY, opioid peptides, galanin, vasopressin, and 
GHRH (Bray 1992). Thus, feeding behaviour is controlled by the antagonist effects of 
anorexigenic and orexigenic biomolecules. The complex mechanisms underlying the 
abundance of such variety of feeding behaviour-modulating substances can be understood 
on the basis of, the specific role for each molecule as a regulatory mechanism in energy 
balance status, the specifity of macronutrient intake (carbohydrate, fat or proteins) and meal 
size control, and the shifts in feeding behaviour related to hormonal status, gender, age, and 
circadian rhythms (Leibowitz 1992). 
It is accepted that cells of several hypothalamic nuclei detect circulating satiety signals and 
transmit this information to other brain areas. Anorexigenic and orexigenic biomolecules are 
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located in VMH, LH, PVN and ARC interacting one to others in a way that they may induce 
a characteristic feeding behaviour. Thus, peptide Y (Y3-36) is released from gastrointestinal 
tract postprandially, and acts on NPY Y2 receptor in the ARC to inhibit feeding with a “long-
term” effect (Batterham et al., 2002). On the contrary, other satiety signals induced by gut-
brain peptides such as GLP-1, GLP-2 and CCK produced (Navarro et al., 1996; Turton et al., 
1996; Rodriquez de Fonseca et al., 2000; Tang-Christensen et al., 2000) a “short-term” effect, 
while insulin and leptin (Batterham et al., 2002) inhibit the appetite by increasing the 
formation of POMC and reducing NPY action. In addition, ghrelin a peptide released by the 
stomach is stimulated before the meals to facilitate NPY action (Coiro et al., 2006). 
 
ANOREXIGENIC OREXIGENIC 
CART Leptin AGRP 
CCK α-MSH Galanin 
CRH Neurotensin Ghrelin 
GLP-1 Oxytocin MCH 
GHRH Pro-opiomelanocortin Noradrenaline 
GLP-2 Peptide  Y (Y 3-36) NPY 
IL-1┚ TRH Opioid peptides 
Insulin Serotonin Orexin A and B 
 Urocortin  
Table 1. Anorexigenic and orexigenic biomolecules implied in the control of feeding 
behaviour. 
Intracerebroventricular or subcutaneous administration of GLP-1 produced a marked 
reduction of food intake and water ingestion. Exendin-4, proved to be a potent agonist of  
GLP-1R also decreased both food and water intake in a dose-dependent manner, while 
exendin (9-39) considered as an antagonist of the GLP-1R, reversed the inhibitory effects of 
GLP-1 or exendin-4 (Navarro et al., 1996; Turton et al., 1996; Rodriguez de Fonseca et al., 
2000). Additionally, icv administration of GLP-1 to mice and rats produced a marked 
decrease of food intake but not of water ingestion. Surprisingly, this effect was avoided by 
the administration of exendin (9-39) (Tang-Christensen et al., 2000) . 
5.2 Hypothalamic slices as a physiological model for the study of hypothalamic 
regulation by glucose and peptides 
Some hypothalamic neuronal cell models have been generated from embryonic and adult 
animals to carry out molecular genetic analysis of hypothalamic neuronal function. Some 
examples are the GT1-7 and N1E-115 cell lines or the recently hypothalamic neuronal cell 
models generated by Belsham´s group (Dalvi et al., 2011). However, the use of 
organotypic slice cultures is an approach with many advantages. A broad range of studies 
shows that organotypic cultures retain many in vivo characteristics as regards, neuronal 
morphology, cellular and anatomical relations and network connections (Sundstrom et al., 
2005). The advantages of the slices culture are the isolated and well defined environment 
of the in vitro preparations and in this way several brain areas have been studied 
(hippocampus, cerebellum, cortex, striatum, brain stem structures, spinal cord, retina and 
hypothalamus).  
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For these reasons, these cultures are increasingly been used as models to investigate 
mechanisms and treatment strategies for neurodegenerative disorders or exposure to 
neurotoxic compounds (Kristensen et al., 2003), traumatic brain injury (TBI) (Morrison et al., 
2006) and neurogenesis (Lossi et al., 2009). Hypothalamic slices have also been frequently 
used for electrophysiological studies developed in vitro to evaluate the firing rate of specific 
neurons located in VMH and LH (Yang et al., 1999) 
Most hypothalamic organotypic slice cultures have been derived from neonatal animals. In 
fact, slices of developing brain tissue can be grown for several weeks as so called 
organotypic slice cultures (Noraberg et al., 2005),  but also adult rats have been used. In this 
sense our group have used short-term hypothalamic slices cultures, obtained from adult rat, 
to test the effect of different peptides on the gene expression and enzymatic activity in the 
VMH and LH areas (Sanz et al., 2007; Sanz et al., 2008). Thus, the hypothalamic organotypic 
cultures are a useful model for the study of the physiological effect of some peptides on 
specific hypothalamic nuclei, which could be dissected after the treatment and analyzed by 
enzymatic, molecular, biochemical or histological procedures.  
5.3 Interactions between anorexigenic peptides and cerebral glucose metabolism in 
humans 
By previous studies we know that GLP-1 is an anorexigenic peptide. The proglucagon gene is 
expressed mainly in the brainstem and hypothalamus, through a mRNA transcript identical to 
that produced in pancreas and intestine (Drucker & Asa 1988), which permits the formation of 
glucagon-related peptides in the brain. Furthermore, the hypothalamus and brainstem are the 
areas with the highest concentration of GLP-1 and its receptors (Uttenthal et al., 1992), 
suggesting that this peptide has a local function, as well as a more remote signalling role. The 
expression of GLP-1R gene gives rise to a protein with effects on the selective release of 
neurotransmitters (Mora et al., 1992), appetite and fluid homeostasis, as well as serves as a 
signal to reduce food intake (Navarro et al., 1996; Turton et al., 1996; Rodriquez de Fonseca et 
al., 2000). Also, the coexpression of GLP-1R with those of GLUT-2 and GK in the same cells 
suggest that these proteins play a role in glucose sensing (Navarro et al., 1996). A further step 
was to evaluate the GLP-1 effect on cerebral-glucose metabolism in control subjects by 
positron emission tomography (PET), using 2-F-18 deoxy-D-glucose (FDG). PET is an imaging 
technology in which compounds labelled with positron-emitting radioisotopes serve as 
molecular probes to identify and determine biochemical processes in vivo. 
We used (Alvarez et al., 2005) intravenously injected FDG to trace the transport and 
phosphorylation of glucose in brain. FDG-6-phosphate is the end product of the process of 
glucose metabolism and it is not a substrate for subsequent metabolic reactions then it is 
retained in the cell proportionately to the rate of glycolysis. The activity measured reflects 
FDG transport and phosphorylation by the cells and, in the case of the hypothalamus and 
brainstem which contains cells expressing GLUT-2 and GK, may provide some information 
about brain glucose sensing.  
PET imaging was sensitive to GLP-1 administration (Figure 4). Thus, this peptide 
significantly reduced cerebral glucose metabolism in the hypothalamus and brainstem as 
compared with the data obtained in normal control subjects without GLP-1 administration. 
These changes can be explained in terms of this peptide can enter the brain by binding to 
blood barrier-free organs such as the subfornical organ and the area postrema (Orskov et al., 
1996). Also, it could be transported into the brain through the choroid plexus, which has a 
high density of GLP-1 receptors. 
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Fig. 4. PET of glucose metabolism in brains of human controls subjects, i.v. perfused with or 
without GLP-1 (0.75 pmol/Kg body weight for 30 minutes). The differences between both 
tests were of 6 months, and were projected on sagittal normalized brain MRI. PET imaging 
was sensitive to the peptide administration. Thus GLP-1 significantly reduced (p<0.001) 
cerebral glucose metabolism in the hypothalamus and brainstem as compared with the data 
obtained in normal control subjects without peptide administration. 
Using PET technology we observed that iv administration of GLP-1 produced a significant 
reduction in carbohydrate metabolism in selective areas of the brain, including the 
hypothalamus and brainstem, both areas involved in feeding behaviour. Thus, the 
accumulation of FDG-6-phosphate into the cells serves to assess the facilitated transport and 
hexokinase phosphorylation of glucose, which, in the case of hypothalamus and brainstem 
cells containing GLUT-2 and GK, might facilitate the glucose-sensing process. These 
findings are of interest because glucoreceptive sites controlling food intake and blood 
glucose have been found in the medulla oblongata and mesencephalon of the rat (Ritter et 
al., 2000), in addition to those reported in the hypothalamus. Also, GLP-1 is expressed in 
human brain, and it most likely mediates the effect of GLP-1 on glucose metabolism in 
selective areas of hypothalamus and brainstem; it may also facilitate the process of glucose 
sensing in these areas. Because the reduced number of neurons involved in glucose sensing 
(Oomura et al., 1969; Ashford et al., 1990) , approximately 40% of cells in the VMH and 30% 
of cells in the LH, PET imaging offers a good procedure for identifying these cell signals in 
vivo more accurately compared with the more commonly used in vitro procedures. 
These findings provide first evidences of the action of an anorexigenic peptide on glucose 
metabolism in the hypothalamus and brainstem, and might explain the satiety–induced 
effects of peripheral or central administration of GLP-1 and the central alterations produced 
by the iv administration of the peptide. Furthermore, open new doors for studying the effects 
of other regulatory peptides in subjects under control and pathophysiological situations.  
6. Others hypothalamic metabolic sensors: AMPK structure and regulation 
AMP-activated protein kinase (AMPK) functions as a cellular energy sensor being activated 
during energy depletion. The kinase is mainly activated by an increase AMP/ATP ratio. 
Activation of AMPK regulates a large number of downstream targets stimulating ATP-
generating, catabolic pathways and inhibiting anabolic pathways (Hardie et al., 1998; Rutter 
et al., 2003). 
AMPK is a heterotrimeric serine/threonine kinase consisting of a catalytic ┙-subunit 
encoded by 2 genes (┙1 or ┙2), a ┚-subunit encoded by 2 genes (┚1, ┚2) and a regulatory ┛-
subunit encoded by 3 genes (┛1, ┛2, ┛3). Different isoforms and alternative splicing of some 
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mRNAs encoding these subunits, give rise to large variety of heterotrimeric combinations 
(Hardie 2007; Viollet et al., 2009). It is known that some tissues can express several types of 
AMPK complexes.  
AMPK can be regulated by an allosteric mechanism, through AMP binding to ┛ subunit, 
and by covalent phosphorylation at Thr172 located in the kinase domain of the ┙-subunit. 
The level of phosphorylation is also regulated by AMP through stimulation of upstream 
kinases and by inhibition of dephosphorylation by protein phosphatases. One of the 
identified upstream kinases of AMPK is the tumor-suppressor (Liver Kinase B1: LKB1). In 
neural and endothelial cells AMPK may be also activated by rises in cytosolic Ca2+ 
concentration. The calmodulin-dependent protein kinase kinase (CaMKK) can also activate 
AMPK by phosphorylation of Thr172. 
The AMPK is able to detect changes in cellular energy state that occur in response to 
variations in nutrient concentrations. Any cellular or metabolic stress that reduces ATP 
production or accelerates ATP consumption will increase the ratio of the ADP/ATP, which 
will be amplified by the action of adenylate kinase resulting in increased AMP/ATP with 
consequent activation of AMPK. Once activated, AMPK first directly affects the activity of 
key enzymes of glucose metabolism and fatty acids and at a second more long term 
regulates transcriptional control of the main elements involved in these metabolic pathways. 
The net result of the activation of AMPK will restore energy balance inhibiting anabolic 
pathways responsible for the synthesis of macromolecules. (Figure 5) 
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acids acidoxidation
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Fig. 5.AMPK regulation of downstream metabolic events. AMPK restores energy balance by 
activation of processes that produce energy and inhibition of those that consume energy. 
6.1 Role of AMPK in hypothalamic glucose sensing 
AMPK is broadly expressed throughout the brain with a mainly neuronal distribution 
(Turnley et al., 1999). Hypothalamic AMPK has been proposed to play a role in the central 
regulation of food intake and energy balance. In this way, fasting increases and re-feeding 
decreases AMPK activity in various hypothalamic nuclei (Minokoshi et al., 2004). Several 
studies have demonstrated that hypothalamic AMPK is regulated by blood glucose levels. 
Peripheral or central hyperglycaemia inhibits AMPK in several hypothalamic nuclei. 
Insulin-induced hypoglycaemia and inhibition of intracellular glucose utilization through 
the administration of 2-deoxyglucose both increased hypothalamic AMPK activity and food 
intake. 
The use of catalytic subunit of AMPK knockout mice (AMPK┙1-/- and AMPK┙2-/-) indicated 
that AMPK┙1-/- mice has no metabolic alterations, whereas AMPK┙2-/- mice showed 
insulin-resistance characterized by impaired insulin stimulated whole-body glucose 
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utilization and skeletal muscle glycogen synthesis and reduced insulin secretion. However, 
they showed no apparent changes in body weight and food intake (Viollet et al., 2009).  
In the last years AMPK has been proposed as a cellular energy sensor that is able to 
assemble many regulatory signals and nutritional environmental changes, also involved in 
maintaining whole body energy balance (Hardie et al., 2006). Regulation of AMPK activity 
in hypothalamic areas involved in the control of feeding behaviours have  been also 
described as a mechanism to detect nutritional variations including glucose levels 
(Mountjoy & Rutter 2007). Neurons implied in the control of food intake have as well 
glucose sensor that respond to fluctuations in extracellular glucose levels.  
In general most cells will express glucose transporters that have high affinity for glucose; 
therefore ATP synthesis by glucose metabolism only stops when glucose levels are 
pathologically low. However, cells that have a glucose sensor mechanism, express GLUT-2 
and GK. The presence of these proteins of high Km for transport and metabolism of glucose 
will allow that ATP synthesis decreases when decreases the concentration of glucose in the 
physiological range and this allows that in these cells the AMPK can be activated by low 
levels of glucose and inhibited by high glucose levels in the physiological range. 
The hypothalamic AMPK role has been studied in vivo by expression of AMPK mutants: 
Inhibition of hypothalamic AMPK suppresses neuronal NPY/AgRP signalling and inhibit 
food intake. However, elevated AMPK increases NPY/AgRP expression, food intake and 
body weight (Minokoshi et al., 2004).  
The role of AMPK in the two major subpopulations of neurons involved in the regulation of 
feeding was later analyzed by knock out of AMPK┙2 in specific neurons of mice. The results 
showed that genetic deletion of AMPK┙2 in hypothalamic POMC neurons (POMC 
AMPK┙2-KO) developed obesity. However, AMPK┙2 specifically knocked in AgRP 
neurones (AgRP AMPK┙2-KO) exhibited an age-related lean phenotype (Claret et al., 2007). 
Those mice do not respond to changes in extracellular glucose. The unexpected results 
suggest that absence of AMPK in orexigenic AgRP neurons reduced body weight, whereas 
lack of AMPK in anorexigenic POMC neurons increased body weight. These results suggest 
a role for AMPK as a common glucose-sensor in these neurons (Claret et al., 2007). It is 
important to emphasize that GE neurons do not overlap completely with POMC neurons in 
the ARC while the GI neurons do not completely overlap with NPY⁄AgRP neurons. Those 
findings indicated the complexity of the functions of hypothalamic AMPK. 
6.2 Regulation by orexigenic and anorexigenic peptides 
Several reports indicate that AMPK is also regulated by several orexigenic and anorexigenic 
signals (Minokoshi et al., 2004). Thus, hypothalamic AMPK activity was inhibited in ARC 
and PVN by anorexigenic peptides as leptin and insulin by contrast, orexigenic peptides 
(ghrelin) increased specifically ┙2AMPK activity  
In other hand, other studies reported AMPK-independent pathways. The effect of leptin 
were maintained in POMC ┙2AMPK-KO neurons and insulin depolarised AgRP neurons in 
AgRP ┙2AMPK-KO (Claret et al., 2007). The different results may be explained, in addition 
to the different techniques and experimental setups, by the presence of distinct 
subpopulations of GE and GI neurons with different neuropeptide phenotypes, responses to 
hormonal stimuli and, in some cases, different glucose-sensing mechanisms. 
The downstream pathways of AMPK in the hypothalamus may involve the acetyl-CoA 
carboxylase (ACC)-malonyl-CoA-carnitine palmitoyltransferase 1 (CPT1) pathway and the 
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Fig. 6. Regulation of hypothalamic AMPK activity. Downstream targets involved in this 
signaling pathway. Several orexigenic and anorexigenic peptides regulate AMPK activity. 
Some of downstream targets of AMPK in the hypothalamus: ACC, acetyl-CoA carboxylase; 
CPT1, carnitine palmitoyltransferase 1. The effect of AMPK on the mammalian target of 
rapamycin (mTOR) pathway has not been directly proved in the hypothalamus.  
mammalian target of rapamycin (mTOR) pathway. Activation of ACC, as a consequence of 
AMPK inhibition, would lead to increased intracellular malonyl-CoA levels, which would 
inhibit mitochondrial CPT1 and fatty acid oxidation.  
The mTOR is another possible target of AMPK (Figure 6). AMPK inhibits mTOR signalling, 
thereby suppressing protein synthesis, which is an important pathway by which AMPK 
conserves cellular energy. The mTOR signalling pathway plays a crucial role in the 
regulation of food intake and body weight in the hypothalamus (Cota et al., 2006; Ropelle et 
al., 2008). The mTOR is colocalized with AgRP/NPY and POMC neurons in the ARC (Perrin 
et al., 2004). Fasting downregulates mTOR signalling, whereas re-feeding activates it.  
Interestingly, hypothalamic AMPK also mediates the counter-regulatory response to 
hypoglycaemia, increasing the release of peripheral hormones such as corticosterone, 
catecholamines and glucagon (Han et al., 2005; McCrimmon et al., 2006). Thus AMPK is not 
only a peripheral or a central mediator, but also a key enzyme in coordinating the 
interaction between peripheral and central energy regulation. 
It is generally accepted that in peripheral organs, fuel overabundance alters the activity of 
metabolic sensors (decreased AMPK and increased the mTOR and its down-stream target 
the S6Kinase (p70S6K)) causing insulin resistance (Kola et al., 2005).  
AMPK and mTOR activity respond to changes in glucose and other nutrients in hypothalamic 
centres involved in control of feeding and deregulation of this signalling pathways might be 
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implied in the develop of obesity and diabetes type 2. GLP-1 treatment to type 2 diabetic 
subjects normalizes fasting levels of blood glucose and decreases glucose levels after ingestion 
of a meal (Niswender 2010). GLP-1 is able to induce several effects that contribute to feeding 
behaviour. Preliminary data from our laboratory also suggest that, at least some of those 
effects, might mediate through regulation of AMPK and p70S6K in VMH and LH.  
7. Conclusions 
Glucoregulatory mechanisms are of primary functional concern to provide a continued 
glucose supply to the central nervous system and to face metabolic needs of peripheral 
tissues. Glucose sensors are molecular designs that accurately measure glucose 
concentrations in the extracellular space facilitating the mechanisms need to maintain 
glucose homeostasis. GK might be responsible of glucose sensing in some of hypothalamic 
GE and GI neurons (VMH, LH ARC, PVN and dorsomedial nucleus). GK properties of high-
Km phosphorylation of glucose and that it is not inhibited by glucose-6-phosphate, enable 
that glucose catabolism be proportional to glucose levels in the extracellular space. Also, the 
functional coexpression of GK with GLUT-2, GKRP and GLP-1R in hypothalamic areas 
implied in feeding behaviour, could orchestrate regulatory signals to maintain body weight 
and energy balance. Glucose, orexigenic and anorexigenic peptides contribute to control GK, 
as well as other energetic sensors such as AMPK. The effect of nutrients occurs on GK and 
AMPK enzyme activities as required by a short-term response and in a distinctive pattern 
between VMH and LH. Also, GLP-1 produced a significant reduction of glucose metabolism 
in selective areas of human brain including hypothalamus and brainstem, both areas 
involved in feeding behaviour. These findings open new doors for studying the effects of 
others regulatory peptides in subjects under control and pathophysiological situations. In 
summary, this chapter has shown a view of the complexity of the network of regulatory 
signals, where GK, AMPK and regulatory peptides are involved, leading to an optimal 
energy balance and body weight. 
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